Search
for
Sort by
Research 541–570 of 1000+
- Case Report: PTCH1 splice-site mutation and sonidegib treatment in Gorlin-Goltz syndrome: clinical insights from a family case study
- Management of patients and side effects during cyclosporine therapy for cutaneous disorders
- Cosmetic Approach for Men
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Pesquisa e desenvolvimento de produtos cosméticos para o público masculino com óleos essenciais: caracterização da pele, eficácia clínica, perfil de consumo e influência da publicidade
- Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials
- Examination of epigenetic inhibitor zebularine in treatment of skin wounds in healthy and diabetic mice
- Endocrine intervention for transsexuals
- Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials
- Phase I Clinical Trial: Evaluating the Efficacy, Safety, and Patient Satisfaction of Platelet‐Rich Plasma (PRP) Injections and Microneedling for Androgenetic Alopecia Treatment
- Efficacy and safety of microneedling radiofrequency in patterned hair loss
- A Survey of Medicinal Plants on Acharya Prafulla Chandra College Campus
- Skin phenotype diversity across populations: from skin morphology to molecular phenotype
- Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering
- Hair growth stimulated by allogenic adipose-derived stem cells supplemented with ATP in a mouse model of dihydrotestosterone-induced androgenetic alopecia
- INTEGRATION OF ARTIFICIAL INTELLIGENCE IN DRUG DEVELOPMENT AND MANUFACTURING: EVALUATING THE EFFICACY OF MINOXIDIL AND SILDENAFIL IN ALOPECIA TREATMENT
- The role of 3Rs in the age of One Health: where we are and where we’re going
- How drug repurposing can advance drug discovery: challenges and opportunities
- Drug Repurposing: Accelerating New Therapeutic Discoveries from Old Molecules (1990 – 2025)
- Redefining Drug Discovery: A Review of Drug Repurposing –Approaches, Benefits and Breakthroughs
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Role of Drug Repurposing in Sustainable Drug Discovery
- Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and Future Perspectives
- SYNERGIA AI I MEDYCYNY: SZANSE I WYZWANIA
- Catechol-chitosan/polyacrylamide hydrogel wound dressing for regulating local inflammation
- MendelVar: gene prioritization at GWAS loci using phenotypic enrichment of Mendelian disease genes
- DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
- Coexistence of alopecia areata and fixed drug eruption: An uncommon isotopic phenomenon?
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Real-world pharmacovigilance insights into drug-induced risk of alopecia